[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-303049-105":53,"doc-detail-303049-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","2026-gasco-corporate-partnership-invitation-letter","2026 GASCO Corporate Partnership Invitation Letter","","Invitation letter from the Georgia Society of Clinical Oncology (GASCO) to Georgia Cancer Care Community colleagues to continue corporate support for the 2026 Corporate Partnership. It defines the agreement period from January 1, 2026 through December 31, 2026, outlines GASCO’s mission and professional and educational collaborations, and lists planned 2026 meetings with continuing education credits. It requests returning the Corporate Partnership Commitment Form by December 31, 2025 and specifies funding and pre-payment terms for exhibit reservations.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":41,"@type":70,"position":76},"https://docshare.wps.com/template/letters/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/2026-gasco-corporate-partnership-invitation-letter/303049/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/2026-gasco-corporate-partnership-invitation-letter/303049.png","ImageObject",442,249,{"name":88,"@type":89},"Rizky","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-04","2026-09-19",true,{"@type":98,"interactionType":99,"userInteractionCount":76},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is the agreement period for the 2026 GASCO Corporate Partnership?","Question",{"text":108,"@type":109},"The agreement year runs from January 1, 2026 through December 31, 2026.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"Which 2026 GASCO meetings are mentioned for continuing education credits?",{"text":113,"@type":109},"The letter lists March 6-8, 2026 (Annual Board Retreat), August 21-22, 2026 (Annual Meeting and Best of ASCO®), and an October or November 2026 Fall Meeting with venue and date to be determined.",{"name":115,"@type":106,"acceptedAnswer":116},"When must the Corporate Partnership Commitment Form and annual funding be submitted?",{"text":117,"@type":109},"The Commitment Form must be returned by December 31, 2025. Annual funding for Platinum through Level III Corporate Partners is due no later than January 31, 2026.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},303049,1790484967,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":40,"category_name":41,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":76,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":76,"language":135,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":61,"update_tm":139,"read_time":9},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","3330 Cumberland Blvd Suite 650 Atlanta, GA 30339  \nBoard of Directors  \nChirag Jani, MD President • Ticiana Leal, MD Vice-President, President-Elect Secretary/Treasurer • Gregory Harris, DO Secretary/Treasurer  \nSharad Ghamande Immediate Past President • Bradley C. Carthon, MD, PhD Melissa Dillmon, MD, FASCO John French, MDCrain Garrot, MD Christopher Hagenstad, MD Anand Jillella, MD Petros Nikolinakos, MD Samantha Shams, MD Alison Spellman, MD Srividya Srinivasamaharaj, MD  \nGASCO Officers  \nPeter F. Lyle, Sr.  \nExecutive Director  \n•  \nKaren M. Beard  \nDirector  \n770-951-1018  \n[info@gasco.us](info@gasco.us)  \n[www.gasco.us](www.gasco.us)  \n[fax](fax 770-951-2157)[ 770-951-2157](fax 770-951-2157)  \nSeptember 15, 2025  \nRE: Invitation for 2026 GASCO Corporate Partnership  \nTo Our Colleagues in the Georgia Cancer Care Community:  \nOn behalf of the Georgia Society of Clinical Oncology (GASCO), we thank you for your past support of our programs and invite you to continue your supporting Corporate Partnership with GASCO for 2026. The agreement year is from January 1, 2026, through December 31, 2026.  \nGASCO values our Corporate Partnerships as your financial and professional collaborations over the years have allowed GASCO to build a solid reputation within the cancer care community as one of the top organizations of its kind in the country. We are recognized as an innovative and effective organization with a membership that represents the majority of cancer specialists in both academic and community settings in Georgia. GASCO’s membership includes medical oncologists, hematologists, radiation oncologists, surgical oncologists, pathologists, Advance Practice Providers, oncology pharmacists and nurses and other administrative support professionals. GASCO’s Administrators’ Association and Cancer Patient Navigators of Georgia Association ensure that GASCO can be responsive to the clinical and economic needs of the practices and their patients.  \nA touchstone of our mission is GASCO’s commitment to innovation, collaboration, education, and communication in serving the cancer care community. Our Board of Directors represents key members of the academic and major community hospital systems in Georgia. Many are nationally recognized and also serve in important roles within organizations involved with cancer research. We continue to develop innovative programs and projects in conjunction with the American Society of Clinical Oncology (ASCO®), the Georgia Center for Oncology Research and Education (Georgia CORE), the Winship Cancer Institute of Emory University, Augusta University, Morehouse School of Medicine, the Association of Oncology Nurse Navigators (AONN), and the Georgia Association of Pathologists (GAP) .  \nOur educational collaborations with Georgia CORE and the state medical schools are aimed toward providing less duplication on content while allowing each part of the team to contribute based on their core competencies. This has resulted in well-attended and  \n770-951-1018 [info@gasco.us](info@gasco.us)  \n[www.gasco.us](www.gasco.us)  \n[fax](fax 770-951-2157)[ 770-951-2157](fax 770-951-2157)  \nclinically robust meetings for all our constituents as well as success in improving access to clinical trials and translational oncology fields. Our Advocacy work with the Georgia State Legislature and national cancer centric organizations, such as ASCO® and the American Cancer Society have led to important legislation related to patient care access and provided templates for other state oncology societies to use to affect change in their states.  \nIn 2026, we are planning educational offerings related to new preventive and therapeutic advancementsin cancer care. Our 2025 educational programs continued to be highly rated by attendees and have been of high value to our Corporate Partners. In fact, we had a record attendance at our 2025 GASCO Annual Meeting and Licensed Best of ASCO® .  \nPlans for 2026 meetings with continuing education cre","cbCaijaD8vLyrEmG","https://ap.wps.com/l/cbCaijaD8vLyrEmG","pdf",456091,"English","# Invitation for 2026 GASCO Corporate Partnership\n## Agreement period and organizational value\n## 2026 educational offerings and meeting dates\n## Commitment form and funding/pre-payment deadlines","[{\"question\":\"What is the agreement period for the 2026 GASCO Corporate Partnership?\",\"answer\":\"The agreement year runs from January 1, 2026 through December 31, 2026.\"},{\"question\":\"Which 2026 GASCO meetings are mentioned for continuing education credits?\",\"answer\":\"The letter lists March 6-8, 2026 (Annual Board Retreat), August 21-22, 2026 (Annual Meeting and Best of ASCO®), and an October or November 2026 Fall Meeting with venue and date to be determined.\"},{\"question\":\"When must the Corporate Partnership Commitment Form and annual funding be submitted?\",\"answer\":\"The Commitment Form must be returned by December 31, 2025. Annual funding for Platinum through Level III Corporate Partners is due no later than January 31, 2026.\"}]","2026 GASCO Corporate Partnership Invitation Letter | PDF",1789799794]